Skip to main content
SpringerLink
Log in

Improving outcome after positive interim PET in advanced Hodgkin’s disease: reality vs expectation

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Poulou LS, Karianakis G, Ziakas PD. FDG PET scan strategies and long-term outcomes after first-line therapy in Hodgkin’s disease. Eur J Radiol. 2008;in press.

  2. Jabbour E, Hosing C, Ayers G, et al. Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma. Cancer 2007;109:2481–9.

    Article  PubMed  Google Scholar 

  3. MacManus MP, Seymour JF, Hicks RJ. Overview of early response assessment in lymphoma with FDG-PET. Cancer Imaging 2007;7:10–8.

    Article  PubMed  Google Scholar 

  4. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007;110:3507–16.

    Article  PubMed  CAS  Google Scholar 

  5. Gallamini A, Hutchings M, Rigacci L, et al. Early interim 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian–Danish study. J Clin Oncol 2007;25:3746–52.

    Article  PubMed  CAS  Google Scholar 

  6. Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006;107:52–9.

    Article  PubMed  CAS  Google Scholar 

  7. Dann EJ, Bar-Shalom R, Tamir A, et al. Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome. Blood 2007;109:905–9.

    Article  PubMed  CAS  Google Scholar 

  8. Horning SJ. Risk, cure and complications in advanced Hodgkin disease. Hematology Am Soc Hematol Educ Program 2007;2007:197–203.

    PubMed  Google Scholar 

  9. Gobbi PG, Levis A, Chisesi T, et al. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin’s lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. J Clin Oncol 2005;23:9198–207.

    Article  PubMed  CAS  Google Scholar 

  10. Moskowitz CH, Kewalramani T, Nimer SD, et al. Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin’s disease. Br J Haematol 2004;124:645–52.

    Article  PubMed  Google Scholar 

  11. Majhail NS, Weisdorf DJ, Defor TE. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin’s lymphoma. Biol Blood Marrow Transplant 2006;12:1065–72.

    Article  PubMed  Google Scholar 

  12. Jantunen E, Itala M, Siitonen T, et al. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990–2003. Eur J Haematol 2006;77:114–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplantation Unit, “Hygeia” Diagnostic and Therapeutic Centre, 4 Erythrou Stavrou Street, 151 23, Athens, Greece

    Panayiotis D. Ziakas

  2. Department of Computed Tomography and Interventional Radiology, “Sotiria” General Hospital for Chest Diseases, Athens, Greece

    Loukia S. Poulou

Authors
  1. Panayiotis D. Ziakas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Loukia S. Poulou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Panayiotis D. Ziakas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziakas, P.D., Poulou, L.S. Improving outcome after positive interim PET in advanced Hodgkin’s disease: reality vs expectation. Eur J Nucl Med Mol Imaging 35, 1573–1575 (2008). https://doi.org/10.1007/s00259-008-0840-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-0840-z

Keywords

Search

Navigation